Schlotmann Andreas, Clorius John H, Clorius Sandra N
Department of Nuclear Medicine and Department of Radiation Oncology, University Hospital Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1665-73. doi: 10.1007/s00259-009-1138-5. Epub 2009 May 13.
The recognition of those hydronephrotic kidneys which require therapy to preserve renal function remains difficult. We retrospectively compared the 'tissue tracer transit' (TTT) of (99m)Tc-mercaptoacetyltriglycine ((99m)Tc-MAG(3)) with 'response to furosemide stimulation' (RFS) and with 'single kidney function < 40%' (SKF < 40%) to predict functional course and thereby need for surgery.
Fifty patients with suspected unilateral obstruction and normal contralateral kidney had 115 paired (baseline/follow-up) (99m)Tc-MAG(3) scintirenographies. Three predictions of the functional development were derived from each baseline examination: the first based on TTT (visually assessed), the second on RFS and the third on SKF < 40%. Each prediction also considered whether the patient had surgery. Possible predictions were 'better', 'worse' or 'stable' function. A comparison of SKF at baseline and follow-up verified the predictions.
The frequency of correct predictions for functional improvement following surgery was 8 of 10 kidneys with delayed TTT, 9 of 22 kidneys with obstructive RFS and 9 of 21 kidneys with SKF < 40%; for functional deterioration without surgery it was 2 of 3 kidneys with delayed TTT, 3 of 20 kidneys with obstructive RFS and 3 of 23 kidneys with SKF < 40%. Without surgery 67 of 70 kidneys with timely TTT maintained function. Without surgery 0 of 9 kidneys with timely TTT but obstructive RFS and only 1 of 16 kidneys with timely TTT but SKF < 40% lost function.
Delayed TTT appears to identify the need for therapy to preserve function of hydronephrotic kidneys, while timely TTT may exclude risk even in the presence of an obstructive RFS or SKF < 40%.
识别那些需要治疗以保留肾功能的肾积水肾脏仍然很困难。我们回顾性比较了(99m)锝-巯基乙酰三甘氨酸((99m)Tc-MAG3)的“组织示踪剂通过时间”(TTT)与“呋塞米刺激反应”(RFS)以及“单肾功能<40%”(SKF<40%),以预测功能转归,从而判断是否需要手术。
50例疑似单侧梗阻且对侧肾脏正常的患者接受了115次配对(基线/随访)(99m)Tc-MAG3肾闪烁显像检查。每次基线检查得出三种功能发展的预测结果:第一种基于TTT(视觉评估),第二种基于RFS,第三种基于SKF<40%。每种预测还考虑了患者是否接受了手术。可能的预测结果为功能“改善”、“恶化”或“稳定”。比较基线和随访时的SKF以验证预测结果。
术后功能改善的正确预测频率为:TTT延迟的10个肾脏中有8个,梗阻性RFS的22个肾脏中有9个,SKF<40%的21个肾脏中有9个;未手术功能恶化的正确预测频率为:TTT延迟的3个肾脏中有2个,梗阻性RFS的20个肾脏中有3个,SKF<40%的23个肾脏中有3个。TTT正常的70个肾脏中,67个未手术时功能得以维持。TTT正常但有梗阻性RFS的9个肾脏中,未手术时无功能丧失;TTT正常但SKF<40%的16个肾脏中,未手术时只有1个功能丧失。
TTT延迟似乎可识别出需要治疗以保留肾积水肾脏功能的情况,而TTT正常即使存在梗阻性RFS或SKF<40%也可能排除风险。